{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:38:40Z","timestamp":1783741120088,"version":"3.55.0"},"reference-count":30,"publisher":"Media Sphere Publishing House","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2023,7,25]]},"abstract":"<jats:p>Objective. To reveal the relationships between antipsychotic and anticholinergic drugs and cognitive functions in patients with schizophrenia. Material and methods. The observational prospective study was conducted at the Bekhterev National Medical Center of Psychiatry and Neurology. The study involved 41 patients (22 men and 19 women) with paranoid schizophrenia, according to ICD 10 criteria, aged 30.12\u00b18.24 years on stable antipsychotic monotherapy or in combination with anticholinergic drug (trihexiphenidyl). Cognitive functions were assessed using the \u00abBrief Assessment of Cognitive Function in Patients with Schizophrenia\u00bb (BACS) scale, severity of mental state and extrapyramidal disturbances were measured using the \u00abPositive and Negative Syndrome Scale (PANSS) and the Simpson-Angus Scale for Assessment of Extrapyramidal Side Effects (SAS). All examination procedures were performed twice at weeks 2 and 8 of therapy. Patients were divided into 2 groups according to the type of antipsychotic therapy. Twelve patients received first generation antipsychotics (FGAs) (group 1), 29 patients received second generation antipsychotics (SGAs) (group 2). Results. Patients receiving SGAs had a significant decrease in the overall SAS score at week 8 of therapy compared with data at week 2, and there was an improvement in cognitive function, unlike patients receiving FGAs. There were also changes on BACS tests the digit sequencing (V=51.5, p=0.007), token motor task (V=75.5, p=0.007) and Tower of London (V=52, p=0.027) only in patients of group 2. Conclusion. The improved tolerance to the drug, as well as cognitive measures, was shown in patients taking SGAs by week 8. Our study confirms the importance of adhering to the minimum effective dose of antipsychotic drugs for the treatment of schizophrenia to prevent cognitive impairment, and to give preference to SGAs in the choice of treatment.<\/jats:p>","DOI":"10.17116\/jnevro202312307180","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T20:18:20Z","timestamp":1690316300000},"page":"80","source":"Crossref","is-referenced-by-count":3,"title":["An effect of antipsychotic and anticholinergic treatment on cognitive function in patients with schizophrenia"],"prefix":"10.17116","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3418-8596","authenticated-orcid":false,"given":"M.A.","family":"Tumova","sequence":"first","affiliation":[{"name":"Bekhterev National Medical Research Center for Psychiatry and Neurology","place":["St. Peterburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4029-9401","authenticated-orcid":false,"given":"A.A.","family":"Stepanova","sequence":"additional","affiliation":[{"name":"Bekhterev National Medical Research Center for Psychiatry and Neurology","place":["St. Peterburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-2147","authenticated-orcid":false,"given":"Y.S.","family":"Zazulina","sequence":"additional","affiliation":[{"name":"Bekhterev National Medical Research Center for Psychiatry and Neurology","place":["St. Peterburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6737-5486","authenticated-orcid":false,"given":"Z.T.","family":"Guseinova","sequence":"additional","affiliation":[{"name":"Bekhterev National Medical Research Center for Psychiatry and Neurology","place":["St. Peterburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6055-1037","authenticated-orcid":false,"given":"M.M.","family":"Zaitseva","sequence":"additional","affiliation":[{"name":"Bekhterev National Medical Research Center for Psychiatry and Neurology","place":["St. Peterburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7373-3825","authenticated-orcid":false,"given":"I.V.","family":"Dyment","sequence":"additional","affiliation":[{"name":"Bekhterev National Medical Research Center for Psychiatry and Neurology","place":["St. Peterburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4826-9688","authenticated-orcid":false,"given":"A.P.","family":"Kotsyubinsky","sequence":"additional","affiliation":[{"name":"Bekhterev National Medical Research Center for Psychiatry and Neurology","place":["St. Peterburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5851-0626","authenticated-orcid":false,"given":"M.V.","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Bekhterev National Medical Research Center for Psychiatry and Neurology","place":["St. Peterburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202312307180-1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01730-X"},{"key":"key-10.17116\/jnevro202312307180-2","doi-asserted-by":"publisher","DOI":"10.31363\/2313-7053-2019-1-26-33"},{"key":"key-10.17116\/jnevro202312307180-3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31205-X"},{"key":"key-10.17116\/jnevro202312307180-4","doi-asserted-by":"publisher","DOI":"10.1001\/JAMAPSYCHIATRY.2013.155"},{"key":"key-10.17116\/jnevro202312307180-5","unstructured":"Dorofeikova MV, Petrova NN. Cognitive dysfunction in schizophrenia and its treatment. Sovremennaja Terapija Psihicheskih Rasstrojstv. 2015;1:2-9. (In Russ.). https:\/\/psypharma.ru\/sites\/default\/files\/1-2015-2-9.pdf"},{"key":"key-10.17116\/jnevro202312307180-6","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291721005523"},{"key":"key-10.17116\/jnevro202312307180-7","doi-asserted-by":"publisher","DOI":"10.1177\/0004867417699473"},{"key":"key-10.17116\/jnevro202312307180-8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2018.04.023"},{"key":"key-10.17116\/jnevro202312307180-9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.107359"},{"key":"key-10.17116\/jnevro202312307180-10","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000790"},{"key":"key-10.17116\/jnevro202312307180-11","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202112108161"},{"key":"key-10.17116\/jnevro202312307180-12","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2021.1912357"},{"key":"key-10.17116\/jnevro202312307180-13","doi-asserted-by":"publisher","DOI":"10.1016\/J.EURONEURO.2019.03.014"},{"key":"key-10.17116\/jnevro202312307180-14","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S96392"},{"key":"key-10.17116\/jnevro202312307180-15","doi-asserted-by":"publisher","DOI":"10.1016\/J.PNPBP.2021.110250"},{"key":"key-10.17116\/jnevro202312307180-16","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119889296"},{"key":"key-10.17116\/jnevro202312307180-17","doi-asserted-by":"publisher","DOI":"10.1016\/J.SCHRES.2022.08.015"},{"key":"key-10.17116\/jnevro202312307180-18","doi-asserted-by":"crossref","unstructured":"Yanushko MG, Ivanov MV, Sorokina AV. Cognitive disorders in indogenous psychoses: contemporary perspective in the light of dimensional approach. Socialnaja i Klinicheskaja Psihiatrija. 2014;24(1):90-95. (In Russ.)","DOI":"10.1016\/j.nmd.2013.12.004"},{"key":"key-10.17116\/jnevro202312307180-19","doi-asserted-by":"publisher","DOI":"10.1016\/J.SCHRES.2017.03.034"},{"key":"key-10.17116\/jnevro202312307180-20","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJP.2019.10.013"},{"key":"key-10.17116\/jnevro202312307180-21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.01.003"},{"key":"key-10.17116\/jnevro202312307180-22","doi-asserted-by":"publisher","DOI":"10.1038\/nature06612"},{"key":"key-10.17116\/jnevro202312307180-23","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"key-10.17116\/jnevro202312307180-24","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199411000-00006"},{"key":"key-10.17116\/jnevro202312307180-25","unstructured":"Lehman AF, Lieberman JA, Dixon LB, et al. American Psychiatric Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2 suppl):1-56"},{"key":"key-10.17116\/jnevro202312307180-26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001556"},{"key":"key-10.17116\/jnevro202312307180-27","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEUROPHARM.2019.05.009"},{"key":"key-10.17116\/jnevro202312307180-28","doi-asserted-by":"publisher","DOI":"10.12740\/PP\/138177"},{"key":"key-10.17116\/jnevro202312307180-29","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEUBIOREV.2015.12.007"},{"key":"key-10.17116\/jnevro202312307180-30","doi-asserted-by":"publisher","DOI":"10.26617\/1810-3111-2018-1(98)-11-17"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T09:48:07Z","timestamp":1745488087000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2023\/7\/1199772982023071080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,25]]}},"alternative-id":["10.17116\/jnevro202312307180"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202312307180","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,25]]}}}